Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

Abroad (travel likely)RecruitingPHASE1

Conditions

Hemophilia B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of haematology and Blood diseases hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lei Zhang, MD) · zhanglei1@ihcams.ac.cn · 0862223909009
Contact: Study coordinator (Feng Xue, MD) · xuefeng@ihcams.ac.cn · +862223909240
Contact: Principal Investigator (Lei Zhang, MD)
Feng Xue, MD (Sub-investigator)

Study leads

Lei Zhang, MD
Principal Investigator
Insitute of haematology and blood diseases hospital, chinese academy of medical sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Healthy Participants · Hemophilia A · Hemophilia B

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Los Angeles, United States

Lentiviral FIX Gene Therapy

Hemophilia B

Abroad (travel likely)RecruitingPHASE1

Shenzhen, China

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Hemophilia B

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States